PBLS Parabilis Medicines, Inc.
Price Chart
Executive Summary
Alan Sebulsky filed a Form 3 initial statement of beneficial ownership with Parabilis Medicines, Inc. (PBLS), indicating a new reporting relationship as an officer, director, or 10% holder. The filing includes a limited power of attorney authorizing company employees to execute future Section 16 filings. This is a routine administrative filing with no material financial or operational impact.
Actionable Insight
This filing is purely administrative and carries no trading signal. Monitor future Form 4 filings for any insider transactions that may provide insight into Sebulsky's conviction or changes in ownership.
Key Facts
- Alan Sebulsky filed a Form 3 initial statement of beneficial ownership with Parabilis Medicines, Inc.
- The filing includes a limited power of attorney appointing Teresa Jurgensen and Thomas Kotarakos to execute future Section 16 filings.
- No securities ownership amounts or transaction details are disclosed in the filing.
Financial Impact
No financial impact — the filing is a routine initial beneficial ownership statement with no disclosed holdings or transactions.
Risk Factors
- No material risks identified from this filing.
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-264596 |
| Document: 0001193125-26-264596-index-headers.html | 0001193125-26-264596 |
| Document: 0001193125-26-264596-index.html | 0001193125-26-264596 |
| Document: 0001193125-26-264596.txt | 0001193125-26-264596 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
3d ago
|
8-K
| $30.30 awaiting T+20 | awaiting T+20 | — | $27.26 (−10.03%) |
|
Jun 10, 2026
4d ago
|
424B4
| $32.16 awaiting T+20 | awaiting T+20 | — | $27.26 (−15.24%) |
|
Jun 10, 2026
5d ago
|
EFFECT
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
3
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
3
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
3
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
3
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
3
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
3
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
Press Release
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access